Full Text
HPR163 Price Implications of the Most-Favored Nation Policy on US Oncology Drug Prices

Abstract

Authors

Alexandra Watt

Back to Volume 28, Supplemental Issue 12S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×